Genetic engineering for disease resistance in crops: Advances and limitations

Introduction

Plant diseases remain one of the most persistent constraints on global agricultural productivity, significantly affecting both yield stability and food security. Across diverse agro-ecological regions, crops are continually challenged by a wide spectrum of pathogens including bacteria, fungi, viruses, and nematodes. Conventional breeding approaches have historically contributed to improving disease resistance; however, their effectiveness is often limited by the availability of resistant germplasm, long breeding cycles, and the rapid evolution of pathogens. In this context, genetic engineering has emerged as a transformative approach that enables precise, targeted, and rapid development of disease-resistant crop varieties.

Lengthy breeding cycles, and the rapid adaptability of pathogens that can overcome resistance mechanisms (Jones & Dangl, 2006; Dangl et al., 2013) [10,16] . In response to these limitations, genetic engineering has emerged as a powerful alternative, offering precise and targeted solutions for enhancing disease resistance in crops. Unlike traditional breeding, which relies on natural variation and recombination, genetic engineering allows direct manipulation of specific genes associated with plant defense, thereby accelerating the development of improved crop varieties (Borrelli et al., 2018a; Chen et al., 2019) [5,6,8] .

Evolution of genetic engineeringin cro improvement

The field of genetic engineering in agriculture has undergone a remarkable transformation over the past few decades. Early approaches primarily focused on transgenic technologies, where foreign genes were introduced into plant genomes to confer desirable traits such as disease resistance. While effective in certain cases, these methods often faced regulatory challenges and public concerns related to biosafety and transgene integration (Halpin, 2005; Kumar et al., 2020) [12,18] . More recently, the advent of genome editing technologies has revolutionized crop improvement strategies. Tools such as CRISPR/Cas systems enable highly precise modifications within the plant genome without necessarily introducing foreign DNA. This shift from transgenic approaches to genome editing represents a major advancement toward more predictable and controlled genetic modifications (Ishino et al., 2018; Chen et al., 2019) [8,14] . Genome editing technologies have been further strengthened by progress in molecular biology, genomics, and bioinformatics, which together have enhanced our understanding of gene function and regulation. These advances allow researchers to identify key genes involved in plant immunity and manipulate them with unprecedented accuracy, paving the way for next-generation crop breeding (Baltes & Voytas, 2015; Jaganathan et al., 2018) [4,15] .

Understanding the plant immune system

A detailed understanding of plant immunity forms the foundation for developing effective genetic engineering strategies. Plants possess a sophisticated immune system composed of two primary defense layers: pattern-triggered immunity (PTI) and effector-triggered immunity (ETI). PTI represents the first line of defense and is activated when plant cells recognize conserved pathogen-associated molecular patterns (PAMPs). This recognition initiates a cascade of defense responses that restrict pathogen invasion. However, some pathogens have evolved effector molecules that suppress PTI, enabling successful infection. In response, plants have developed ETI, a more specialized defense mechanism mediated by resistance (R) proteins that recognize specific pathogen effectors. ETI typically results in a stronger and faster immune response, often associated with localized cell death to prevent pathogen spread (Jones & Dangl, 2006; Kourelis & van der Hoorn, 2018) [16,17] . These two layers of immunity operate in a coordinated manner to protect plants against a wide range of pathogens. However, the evolutionary arms race between plants and pathogens frequently leads to the breakdown of resistance,highlighting the need for durable and broadspectrum strategies (Dangl et al., 2013; Chen et al., 2018) [9,10] .

Genome editing for disease resistance

Recent developments in genome editing, particularly CRISPR/Cas systems, have significantly enhanced the ability to engineer disease-resistant crops. This technology allows precise targeting of genes involved in plant-pathogen interactions, including resistance genes, susceptibility genes, and regulatory elements controlling defense pathways (Arora & Narula, 2017; Paul et al., 2021) [3,22] . One promising strategy involves the modification or knockout of susceptibility (S) genes. These genes are often exploited by pathogens to facilitate infection, and their disruption can lead to durable resistance. For example, targeted editing of susceptibility genes has been successfully used to develop resistance against bacterial and fungal diseases in several crops (Pavan et al., 2010; Zaidi et al., 2018) [21,30] . Another innovative approach is promoter editing, which enables fine-tuning of gene expression without altering the protein-coding sequence. This method minimizes unintended effects while maintaining the plant's normal physiological functions. Additionally, multiplex genome editing allows simultaneous modification of multiple genes, further enhancing resistance durability (Chen et al., 2019;

Yin & Qiu, 2019) [8,28] . [20,23,27] . These examples highlight the potential of genome editing as a precise and efficient tool for crop protection.

Socio-economic and environmental considerations

Beyond technical advancements, the broader implications of genetic engineering in agriculture are increasingly being recognized. Genetically engineered crops have been associated with higher productivity, reduced reliance on chemical pesticides, and improved economic returns for farmers. These benefits contribute to more sustainable agricultural systems and reduced environmental impact (Brookes & Barfoot, 2020) [7] . However, the adoption of genetically engineered crops is influenced by several factors, including regulatory frameworks, biosafety concerns, and public perception. While genome editing technologies are often considered safer and more acceptable than traditional transgenic approaches, uncertainties regarding off-target effects and long-term ecological impacts remain areas of active research (Schaart et al., 2016; Yin & Qiu, 2019) [24] . Therefore, a balanced evaluation of both advantages and limitations is essential to ensure responsible deployment of these technologies. Integrating scientific innovation with policy development and public engagement will be critical for achieving sustainable agricultural transformation.

Scope and objectives of the review

This review aims to provide a comprehensive and critical assessment of recent advances in genetic engineering for enhancing disease resistance in crops. Particular emphasis is placed on genome editing technologies, especially CRISPR/Cas systems, and their applications in modern agriculture. By synthesizing findings from diverse studies, this review seeks to highlight key developments, identify existing challenges, and explore future prospects in this rapidly evolving field. The ultimate goal is to contribute to a deeper understanding of how genetic engineering can be effectively utilized to address plant disease challenges and strengthen global food security. [10,16] . Subsequent studies have significantly expanded knowledge regarding the diversity and functionality of resistance genes. Research has revealed that R genes operate through multiple mechanisms, including both direct interaction with pathogen effectors and indirect recognition via modifications in host proteins. This complexity demonstrates that plant immunity is not governed by a single pathway but rather by an intricate network of signaling events and molecular interactions (Kourelis & van der Hoorn, 2018) [17] . As a result, reliance on single resistance genes often leads to rapid breakdown of resistance due to pathogen evolution. To address this limitation, the concept of gene stacking the combination of multiple resistance genes within a single genotype was introduced as a strategy to achieve broader and more durable resistance (Halpin, 2005) [12] . Empirical evidence supports this approach, showing that combining genes with different modes of action can delay pathogen adaptation and enhance long-term crop protection (Chen et al., 2018) [9] . The emergence of genome editing technologies has transformed the landscape of plant biotechnology, enabling precise and efficient modification of genetic material. Among these tools, CRISPR/Cas systems have gained particular prominence due to their simplicity, versatility, and high efficiency compared to earlier technologies such as zinc finger nucleases and TALENs (Arora & Narula, 2017; Chen et al., 2019) [3,8] . The CRISPR/Cas9 system, originally derived from a prokaryotic immune mechanism, allows targeted editing of specific DNA sequences, making it highly suitable for crop improvement (Ishino et al., 2018) [14] . Its applications in agriculture are extensive, including gene knockout, promoter modification, and multiplex genome editing, all of which contribute to improved disease resistance through distinct molecular pathways (Jaganathan et al., 2018; Paul et al., 2021) [15,22] . Practical applications of CRISPR/Cas9 have demonstrated its effectiveness across a wide range of crop species. For instance, successful editing has been reported in staple crops such as rice and wheat, as well as in horticultural crops like potato and citrus. In rice, targeted mutagenesis of specific transcription factor genes has resulted in enhanced resistance to blast disease (Wang et al., 2016) [27] . Similarly, genome editing has been employed to engineer resistance against bacterial blight by modifying promoter regions associated with susceptibility (Oliva et al., 2019) [20] . These examples highlight the potential of CRISPR technology to deliver precise and heritable resistance traits, thereby accelerating breeding programs and reducing dependence on conventional methods. A particularly innovative strategy in disease resistance breeding involves targeting susceptibility (S) genes rather than introducing resistance genes. Unlike R genes, which actively recognize pathogens, S genes are host factors that pathogens exploit to facilitate infection. Disrupting these genes can therefore hinder pathogen establishment and confer resistance. This approach has gained attention because it often results in broad-spectrum and durable resistance with reduced risk of resistance breakdown (Pavan et al., 2010; Zaidi et al., 2018) [21,30] . For example, editing the promoter region of the CsLOB1 gene in citrus has successfully conferred resistance to citrus canker without adversely affecting plant growth (Peng et al., 2017) [23] . Such findings underscore the effectiveness of S gene modification as a complementary or alternative strategy to traditional resistance breeding. In addition to advances in gene editing, improvements in delivery systems have enhanced the efficiency and Applicability of genetic engineering techniques. Conventional transformation methods, such as Agrobacterium-mediated transformation, are often limited by low efficiency and genotype dependency. To overcome these challenges, researchers have developed virus-mediated delivery systems capable of introducing CRISPR components into plants more rapidly and systemically. This approach enables transient expression of editing machinery, facilitating genome modification without stable integration of foreign DNA (Ali et al., 2015) [2] . Such innovations are particularly valuable for crops that are recalcitrant to traditional transformation techniques, thereby expanding the range of species amenable to genetic improvement. The integration of genome editing with synthetic biology represents another significant advancement in this field. Synthetic biology enables the design and construction of novel genetic circuits and metabolic pathways, which can be combined with precise genome editing tools to create crops with enhanced resistance and improved agronomic performance (Baltes & Voytas, 2015) [4] . This interdisciplinary approach opens new possibilities for engineering complex traits, such as multi-pathogen resistance and stress tolerance, in a coordinated manner. It also allows for the development of customized solutions tailored to specific agricultural challenges. Despite these promising developments, several constraints continue to limit the widespread adoption of genome editing technologies in agriculture. One major concern is the occurrence of off-target effects, where unintended genomic regions are modified. Although advances in CRISPR design and specificity have reduced such risks, they cannot be completely eliminated and require careful validation (Chen et al., 2019) [8] . Regulatory frameworks also vary significantly across countries, creating uncertainty regarding the approval and commercialization of genome-edited crops (Schaart et al., 2016) [24] . In some regions, these crops are regulated similarly to genetically modified organisms (GMOs), while in others they are treated differently based on the absence of foreign DNA. Public perception further influences the acceptance and deployment of genetically engineered crops. Concerns related to biosafety, environmental impact, and ethical considerations often shape policy decisions and market adoption. However, evidence suggests that genetically modified crops have contributed positively to agricultural productivity, economic returns, and environmental sustainability over the past decades (Brookes & Barfoot, 2020) [7] . Addressing public concerns through transparent communication and robust risk assessment is therefore essential for ensuring broader acceptance of genome editing technologies.

Critical review of literature

Overall, the literature clearly indicates that genetic engineering particularly CRISPR-based genome editing has revolutionized the field of disease resistance breeding. By enabling precise manipulation of both resistance and susceptibility genes, these technologies provide powerful tools for developing crops with improved resilience to pathogens. At the same time, achieving sustainable and equitable outcomes will require a balanced approach that integrates technological innovation with regulatory clarity, socio-economic considerations, and public engagement

Methodology

This review was developed through a structured and integrative approach to critically examine advancements in genetic engineering for enhancing disease resistance in crops. Rather than relying on a single stream of evidence, the methodology combined systematic literature screening with thematic synthesis and critical evaluation. This approach ensured that the discussion reflects both foundational concepts and recent innovations in genome editing, plant immunity, and crop improvement. Particular attention was given to the evolution of modern tools such as CRISPR/Cas systems, which have significantly reshaped plant biotechnology research and applications (Chen et al., 2019; Gao, 2018) [9,11] .

a The methodological framework was designed to maintain scientific rigor while enabling a comprehensive understanding of interdisciplinary developments, including molecular biology, plant pathology, and agricultural sustainability.

Literature selection

The process of literature selection followed a targeted yet inclusive strategy to capture key developments in plant genetic engineering related to disease resistance. Peerreviewed journal articles formed the core of the dataset, as they provide validated and high-quality scientific evidence. Foundational studies explaining plant immune systems and resistance mechanisms were prioritized alongside recent research focusing on genome editing technologies such as CRISPR/Cas9 (Jones & Dangl, 2006; Dangl et al., 2013) [10, [16] .

In addition to primary research papers, authoritative review articles and perspective pieces were included to contextualize emerging trends and conceptual advancements. Studies highlighting the application of CRISPR-mediated editing in crops such as rice, potato, and banana were particularly emphasized due to their practical relevance in agriculture (Oliva et al., 2019; Tripathi et al., 2020) [20,25] . The selection also considered research addressing both biotic stress responses and molecular breeding strategies. For instance, studies exploring susceptibility (S) genes and their manipulation were included because they represent a promising route toward durable resistance (Pavan et al., 2010; Van Schie & Takken, 2014) [21,26] . Similarly, work on gene stacking and synthetic biology approaches was reviewed to understand multi-gene resistance strategies (Halpin, 2005; Baltes & Voytas, 2015) [4,12] . To ensure balance, literature spanning different crop systems, pathogen types (fungal, bacterial, and viral), and technological platforms was incorporated. This helped avoid bias toward a single crop or method and allowed for broader generalization of findings.

Inclusion criteria

Clear inclusion criteria were established to maintain consistency and relevance across selected studies. Only those publications that directly contributed to the understanding of genetic engineering approaches for disease resistance in plants were considered. First, studies had to focus on genetic modification or genome editing techniques, particularly those involving CRISPR/Cas systems, TALENs, or other targeted editing platforms. CRISPR/Cas9-based investigations were heavily represented due to their efficiency and widespread adoption in plant research (Arora & Narula, 2017; Jaganathan et al., 2018) [3,15] . Second, the selected studies needed to demonstrate relevance to plant disease resistance mechanisms. This included research on host-pathogen interactions, resistance (R) genes, and susceptibility (S) genes. Investigations into how genome editing alters these pathways to confer resistance were especially prioritized (Kourelis & van der Hoorn, 2018; Zaidi et al., 2017) [17,29] . Third, emphasis was placed on studies that contributed either methodological innovation or practical agricultural application. For example, virus-mediated delivery of CRISPR components and targeted promoter editing were included due to their significance in improving editing efficiency and field applicability (Ali et al., 2015; Peng et al., 2017) [2,23] . Fourth, diversity in crop species and pathogen systems was considered essential. Research involving staple crops such as rice and potato, as well as horticultural crops, ensured that the findings were representative of global agricultural systems (Haverkort et al., 2016; Kumar et al., 2020) [13,18] . Finally, only studies published in reputable, peer-reviewed journals were included to ensure the credibility and reliability of the information synthesized.

Data extraction and synthesis

Following selection, relevant data were systematically extracted from each study and organized into thematic categories. This step was crucial for transforming a large and diverse body of literature into a coherent analytical framework. The extracted information was grouped into four primary themes: (i) plant immune mechanisms, (ii) genome editing technologies, (iii) resistance development strategies, and (iv) socio-economic and regulatory implications. Under plant immune mechanisms, studies describing the structure and function of innate immunity including patterntriggered immunity (PTI) and effector-triggered immunity (ETI) were analyzed (Jones & Dangl, 2006) [16] . The role of resistance genes and their molecular diversity was also examined to understand how plants recognize and respond to pathogens (Kourelis & van der Hoorn, 2018) [17] . The genome editing technologies category focused on tools such as CRISPR/Cas9, highlighting their mechanisms, efficiency, and adaptability across plant systems. Advances in precision breeding and multiplex genome editing were synthesized to identify trends in improving editing accuracy and scalability (Chen et al., 2019; Paul et al., 2021) [8,22] . Resistance strategies included approaches such as gene knockout of susceptibility genes, gene stacking, and cisgenesis. For example, editing of susceptibility genes like OsERF922 and CsLOB1 has been shown to enhance resistance against rice blast and citrus canker, respectively (Wang et al., 2016; Peng et al., 2017) [23,27] . Similarly, broad-spectrum resistance achieved through targeted genome editing was evaluated for its long-term sustainability (Chen et al., 2018) [9] . The socio-economic theme addressed the broader implications of genetically engineered crops, including adoption challenges, regulatory frameworks, and environmental impacts. Studies analyzing the global benefits of GM crops in terms of yield improvement and reduced pesticide use were considered in this context (Brookes & Barfoot, 2020) [7] . After categorization, the extracted data were synthesized to identify patterns, relationships, and emerging research directions. This synthesis enabled the integration of molecular insights with practical agricultural outcomes.

Critical analysis

A critical evaluation of the selected literature was conducted to assess the robustness, limitations, and applicability of existing research. This involved examining experimental design, reproducibility of results, and the scalability of proposed technologies. One key aspect of the analysis was the effectiveness of CRISPR/Cas-based approaches in conferring disease resistance. While many studies reported successful gene edits and improved resistance, challenges such as off-target effects, regulatory constraints, and limited field validation were also identified (Nekrasov et al., 2013; Yin & Qiu, 2019) [19,28] . Another focus was the durability of resistance. Traditional resistance strategies often fail due to pathogen evolution; however, genome editing approaches targeting susceptibility genes offer a more stable alternative. Despite this, concerns remain regarding potential trade-offs in plant fitness and productivity (Pavan et al., 2010; Zaidi et al., 2018) [21,30] .

The analysis also considered the feasibility of deploying these technologies in real-world agricultural systems. While laboratory results are promising, scaling up requires addressing issues such as delivery systems, regulatory approvals, and farmer acceptance. Studies highlighting virus-mediated editing and field-level applications were critically examined for their practical relevance (Ali et al., 2015) [2] . Contradictions in the literature were also explored. For instance, while some studies advocate gene stacking as a robust resistance strategy, others highlight its complexity and potential regulatory hurdles (Halpin, 2005) [12] . Similarly, differing views on the long-term sustainability of CRISPR-edited crops were analyzed to provide a balanced perspective. Overall, this critical approach ensured that the review does not merely summarize findings but evaluates their scientific and practical significance.

Integration of findings

The final stage of the methodology involved integrating insights from diverse studies to construct a unified understanding of genetic engineering for disease resistance in crops. This synthesis bridged the gap between molecularlevel innovations and field-level applications. The integration revealed that genome editing technologies, particularly CRISPR/Cas systems, are central to the future of crop improvement. Their ability to precisely modify genes associated with disease susceptibility and resistance offers unprecedented opportunities for developing resilient crop varieties (Gao, 2018; Zaidi et al., 2017) [11,29] . A key emerging trend is the shift from single-gene resistance to more complex, multi-layered strategies. These include combining gene editing with traditional breeding, exploiting natural genetic variation, and integrating multiple resistance pathways. Such approaches are expected to enhance durability and reduce the risk of resistance breakdown (Chen et al., 2018; Borrelli et al., 2018) [5,6,9] .

The integration also highlighted the importance of interdisciplinary collaboration. Advances in plant biotechnology must be complemented by progress in regulatory science, socio-economic analysis, and farmercentric innovation to ensure successful adoption. Furthermore, the synthesis identified critical knowledge gaps, such as the need for long-term field studies, improved delivery systems, and better understanding of geneenvironment interactions. Addressing these gaps will be essential for translating laboratory successes into sustainable agricultural solutions. In conclusion, this methodological framework enabled a comprehensive and critical evaluation of the current state of genetic engineering for disease resistance in crops. By systematically selecting, analyzing, and integrating relevant studies, the review provides a robust foundation for understanding ongoing advancements and guiding future research and practical applications in agriculture.

Results and critical discussion

The body of literature reviewed reveals a rapid transition from conventional genetic engineering approaches toward highly precise genome editing technologies, particularly CRISPR/Cas systems. While earlier transgenic strategies focused primarily on introducing foreign resistance genes, recent studies emphasize endogenous gene modification, offering greater specificity and potentially improved public acceptance. This shift is evident across multiple studies, highlighting both technological advancement and conceptual evolution in plant disease resistance research.

Evolution from transgenic approaches to genome editing

Earlier work on gene stacking demonstrated the potential of combining multiple resistance traits to enhance durability. However, limitations such as gene silencing, regulatory Complexity, and unpredictable expression patterns restricted its widespread success. In contrast, genome editing approaches discussed in more recent studies provide a more controlled and efficient means of achieving similar outcomes. For instance, multiplex CRISPR editing enables simultaneous targeting of multiple genes, effectively replicating the benefits of gene stacking while minimizing associated challenges. Comparative analysis in figure 4.1indicates that genome editing offers superior precision and reduced time requirements compared to conventional transgenic methods. Studies focusing on CRISPR/Cas systems consistently report higher efficiency, targeted mutagenesis, and fewer unintended effects, although off-target concerns still persist to some extent. The line graph demonstrates the progressive evolution of disease resistance technologies, showing a marked increase in efficiency and precision from conventional breeding to CRISPR-based genome editing. Conventional breeding remains limited by dependence on natural variation and extended selection cycles. The introduction of transgenic approaches improved resistance development through gene stacking, although challenges such as gene silencing and regulatory complexity constrained their effectiveness (Halpin, 2005) [12] . The emergence of genome editing technologies significantly enhanced precision and reduced breeding timelines by enabling targeted modification of endogenous genes (Jaganathan et al., 2018) [15] . The steep increase observed for CRISPR/Cas systems reflects their transformative impact, offering high efficiency, versatility, and ease of use compared to earlier technologies (Chen et al., 2019) [8] . Furthermore, CRISPR-based approaches minimize unintended genetic effects and provide greater control over gene expression, contributing to their rapid adoption in plant biotechnology (Gao, 2018) [11] . Overall, the trend depicted in the graph supports the paradigm shift toward genome editing as the dominant strategy for developing diseaseresistant crops, highlighting its superiority over conventional and transgenic methods in terms of speed, precision, and scalability.

Resistance (r) genes vs susceptibility (s) genes

A major conceptual distinction in the literature lies between strategies targeting resistance genes and those focusing on susceptibility genes. Traditional breeding and early genetic engineering efforts emphasized the introduction or enhancement of R genes. While effective in the short term, these approaches often face durability issues due to pathogen adaptation. In contrast, recent studies strongly support the targeting of susceptibility genes as a more sustainable strategy. Disruption of these genes reduces the ability of pathogens to exploit host cellular mechanisms, thereby conferring broad-spectrum and long-lasting resistance. Comparative evidence suggests that S-gene editing imposes less selective pressure on pathogens, reducing the likelihood of resistance breakdown. However, this approach is not without limitations. Some susceptibility genes play essential roles in normal plant development, and their modification may lead to unintended phenotypic consequences. Therefore, careful selection of target genes and validation of edited lines remain critical. The bar chart (figure 4.2) compares resistance (R) gene-based strategies with susceptibility (S) gene-targeted approaches, highlighting key differences in durability, resistance spectrum, and risk of breakdown. R genes have historically been central to disease resistance breeding, providing strong defense responses through pathogen recognition mechanisms (Kourelis & van der Hoorn, 2018) [17] . However, their effectiveness is often short-lived due to rapid pathogen evolution, leading to frequent resistance breakdown. This limitation is reflected in the higher breakdown risk observed in the graph. In contrast, S-gene disruption represents a novel and more sustainable strategy by eliminating host factors required for pathogen infection (Pavan et al., 2010) [21] . This approach confers broad-spectrum and durable resistance while imposing lower selective pressure on pathogens (Zaidi et al., 2018) [30] . The graph also indicates potential trade-offs, as some susceptibility genes play essential roles in plant development, which may affect yield (Van Schie & Takken, 2014) [26] Overall, the comparative visualization supports the growing consensus that S-gene targeting offers a more robust and long-term solution for disease resistance, while emphasizing the importance of careful gene selection to avoid unintended physiological consequences.

Mechanistic insights: pti and eti integration

Studies on plant immunity consistently emphasize the importance of integrating PTI and ETI mechanisms for effective disease resistance. Earlier frameworks described these pathways as distinct layers, but recent research suggests a more interconnected network of immune responses. Comparative analysis shows that genome editing can be used to enhance both PTI and ETI components. For example, modifying receptor genes can strengthen pathogen recognition, while editing downstream signaling components can amplify defense responses. Additionally, stacking multiple immune pathways through multiplex editing provides a robust strategy for achieving durable resistance. [16] . ETI, in contrast, is a more specific and robust response triggered by interactions between plant resistance proteins and pathogen effectors, leading to amplified defense signaling (Dangl et al., 2013) [10] . The graph demonstrates that different genome editing strategies influence the relative contributions of these immune pathways. Gene knockout approaches primarily enhance PTI by disrupting susceptibility genes, while multiplex editing significantly increases ETI contribution through simultaneous targeting of multiple resistance-related genes (Zaidi et al., 2017) [19] .

Promoter editing shows a balanced contribution, reflecting its role in fine-tuning immune gene expression. The visualization highlights the synergistic interaction between PTI and ETI, supporting the concept that effective disease resistance requires integration of both pathways (Chen et al., 2018) [9] . Overall, the graph reinforces the importance of designing genome editing strategies that leverage this synergy to achieve durable and broad-spectrum resistance in crops.

Delivery systems and technical efficiency

The efficiency of genome editing is heavily influenced by the delivery of editing components into plant cells.

Traditional transformation methods, such as Agrobacteriummediated transformation, are often time-consuming and genotype-dependent. In contrast, virus-mediated delivery systems have demonstrated rapid and systemic expression of CRISPR components, significantly improving editing efficiency The bar chart (figure 4.4) compares major delivery systems used in plant genome editing, highlighting differences in efficiency, speed, and scalability. Agrobacterium-mediated transformation remains a widely used method due to its reliability; however, it is often limited by genotype dependency and longer processing times (Nekrasov et al., 2013) [19] . Biolistic methods offer broader applicability across plant species but may result in lower efficiency and potential tissue damage, affecting transformation success (Arora & Narula, 2017) [3] . Viral delivery systems, in contrast, demonstrate significantly higher efficiency and speed, as they enable rapid and systemic distribution of CRISPR components within plant tissues (Ali et al., 2015) [2] . This enhanced performance is reflected in the graph, indicating their potential for large-scale applications. However, limitations such as restricted cargo size and host specificity remain challenges for viral systems (Baltes & Voytas, 2015) [4] . The visualization emphasizes that the choice of delivery method plays a critical role in determining genome editing outcomes. Overall, the superior efficiency of viral delivery systems suggests a shift toward more advanced and scalable approaches, while also highlighting the need for continued innovation to address existing technical constraints.

Comparative studies indicate that while viral delivery systems offer speed and scalability, they may face limitations in terms of cargo size and host specificity. Therefore, the choice of delivery method must be tailored to the target crop and desired application.

Crop-specific applications and case studies

Analysis across different crops reveals varying degrees of success in applying genetic engineering for disease resistance. Rice has emerged as a model system, with multiple studies demonstrating successful editing of susceptibility genes to confer resistance to bacterial blight and blast diseases. Similarly, citrus and banana studies highlight the potential of promoter editing and gene disruption for managing economically important diseases. [25] In potato, cisgenic approaches have shown promise in enhancing resistance while maintaining genetic integrity. These examples illustrate that while the underlying principles of genome editing are broadly applicable, cropspecific factors such as genome complexity, transformation efficiency, and pathogen diversity influence outcomes. The radar chart (Figure 4.5) presents a multidimensional assessment of genome editing technologies, highlighting both their benefits and limitations across key parameters. High scores in precision, resistance, and yield reflect the strong technical advantages of CRISPR-based approaches, which enable targeted gene modifications and improved crop performance (Yin & Qiu, 2019) [28] . These technologies also contribute to reduced pesticide use and enhanced productivity, supporting sustainable agricultural practices (Brookes & Barfoot, 2020) [7] . Moderate cost values indicate that while initial development expenses may be high, longterm economic benefits can offset these investments (Kumar et al., 2020) [18] . In contrast, lower scores in regulatory approval and public acceptance highlight significant barriers to adoption. Regulatory frameworks for genome-edited crops vary widely across regions, creating uncertainty for commercialization (Schaart et al., 2016) [24] . Public perception also plays a critical role in determining acceptance, influencing policy decisions and market access. The radar chart effectively illustrates the balance between technological potential and socio-economic constraints.

Overall, the visualization supports the conclusion that while genome editing offers substantial benefits for crop improvement, addressing regulatory and societal challenges is essential for its widespread adoption and long-term success. However, comparative analysis also reveals significant variation in regulatory frameworks and public acceptance across regions. While some countries have adopted more flexible regulations for genome-edited crops, others continue to impose strict controls similar to those for transgenic organisms. These differences create challenges for global dissemination and commercialization.

Limitations and research gaps

Despite substantial progress, several limitations persist across studies. Off-target effects remain a concern, particularly in early CRISPR systems, although newer technologies such as base editing and prime editing have improved precision. Delivery efficiency, especially in recalcitrant crops, continues to be a bottleneck. Another critical gap lies in the long-term assessment of genomeedited crops under field conditions. While many studies demonstrate success in controlled environments, fewer provide data on performance across multiple seasons and environments. Additionally, the interaction between edited genes and complex environmental factors requires further investigation.

Future directions

The comparative analysis suggests that the future of genetic engineering for disease resistance lies in the integration of multiple approaches. [2,8,15] . Early conceptual frameworks of plant immunity, particularly PTI and ETI, continue to guide genome editing strategies (Jones & Dangl, 2006; Dangl et al., 2013) [10,16] . Recent studies emphasize targeting susceptibility genes as a durable resistance strategy (Pavan et al., 2010; Zaidi et al., 2018) [21,30] while advancements in delivery systems and precision editing enhance practical applicability (Ali et al., 2015; Gao, 2018) [2,11] .

Conclusion

The comprehensive analysis presented in this review underscores the transformative role of genetic engineering in addressing one of agriculture's most persistent challenges plant diseases. The transition from conventional breeding and transgenic approaches to precise genome editing technologies marks a significant paradigm shift in crop improvement. Tools such as CRISPR/Cas systems have redefined the possibilities of plant biotechnology by enabling accurate, efficient, and targeted manipulation of genes associated with disease resistance. A key insight emerging from the review is the growing emphasis on susceptibility (S) gene targeting as a more durable and sustainable alternative to traditional resistance (R) genebased strategies. By disrupting host factors required for pathogen infection, S gene editing reduces selective pressure on pathogens and enhances long-term resistance. At the same time, integrating multiple strategies such as gene stacking, promoter editing, and multiplex genome editing has been shown to improve resistance durability and broaden the spectrum of protection. Despite these advancements, several challenges remain. Technical limitations, including off-target effects and inefficient delivery systems, continue to restrict the full potential of genome editing, particularly in complex or recalcitrant crop species. Moreover, the lack of long-term field validation and incomplete understanding of gene-environment interactions highlight important research gaps. Beyond scientific constraints, regulatory variability and public perception significantly influence the adoption and commercialization of genetically engineered crops. Looking ahead, the future of disease-resistant crop development lies in integrating genome editing with complementary approaches such as synthetic biology, advanced genomics, and data-driven agriculture. Interdisciplinary collaboration will be essential to translate laboratory successes into scalable and farmerfriendly solutions. Ultimately, achieving sustainable agricultural systems will require not only technological innovation but also supportive policies, transparent communication, and societal acceptance. Genetic engineering, when responsibly deployed, holds immense promise for enhancing crop resilience, reducing environmental impact, and ensuring global food security.

References

1. Aho M, Irshad B, Ackerman SJ, Lewis M, Leddy R, Pope T, et al. Correlation of sonographic features of invasive ductal mammary carcinoma with age, tumor grade, and hormone-receptor status. J Clin Ultrasound. 2013;41(1):10-7. doi:10.1002/jcu.21990.
2. Ali Z, Abul-Faraj A, Li L, Ghosh N, Piatek M, Mahjoub A, et al. Efficient virus-mediated genome editing in plants using the CRISPR/Cas9 system. Mol Plant. 2015;8(8):1288-91. doi:10.1016/j.molp.2015.02.011.
3. Arora L, Narula A. Gene editing and crop improvement using CRISPR-Cas9 system. Front Plant Sci. 2017;8:1932. doi:10.3389/fpls.2017.01932.
4. Baltes NJ, Voytas DF. Enabling plant synthetic biology through genome engineering. Trends Biotechnol. 2015;33(2):120-31. doi:10.1016/j.tibtech.2014.11.008.
5. Borrelli VMG, Brambilla V, Rogowsky P, Marocco A, Lanubile A. Genome editing to improve disease resistance in crops. Int J Mol Sci. 2018;19(11):3415. doi:10.3390/ijms19113415.
6. Borrelli VMG, Brambilla V, Rogowsky P, Marocco A, Lanubile A. The enhancement of plant disease resistance using CRISPR/Cas9 technology. Front Plant Sci. 2018;9:1245. doi:10.3389/fpls.2018.01245.
7. Chen K, Wang Y, Zhang R, Zhang H, Gao C. CRISPR/Cas genome editing and precision plant breeding in agriculture. Annu Rev Plant Biol. 2019;70:667-97. doi:10.1146/annurev-arplant-050718100049.
8. Chen L, Dahlbeck D, Staskawicz B. Engineering broad-spectrum disease resistance in plants. Trends Plant Sci. 2018;23(7):555-68. doi:10.1016/j.tplants.2018.03.006.
9. Dangl JL, Horvath DM, Staskawicz BJ. Pivoting the plant immune system from dissection to deployment. Science. 2013;341(6147):746-51. doi:10.1126/science.1236011.
10. Gao C. The future of CRISPR technologies in agriculture. Nat Rev Mol Cell Biol. 2018;19(5):275-6. doi:10.1038/nrm.2018.2.
11. Halpin C. Gene stacking in transgenic plants the challenge for 21st century plant biotechnology. Plant Biotechnol J. 2005;3(2):141-55. doi:10.1111/j.14677652.2004.00113.x.
12. Haverkort AJ, Boonekamp PM, Hutten R, Jacobsen E, Lotz LAP, Kessel GJT, et al. Durable late blight resistance in potato through dynamic varieties obtained by cisgenesis. Potato Res. 2016;59:35-66. doi:10.1007/s11540-015-9312-6.
13. Ishino Y, Krupovic M, Forterre P. History of CRISPRCas from encounter with a mysterious repeated sequence to genome editing technology. J Bacteriol. 2018;200(7):e00580-17. doi:10.1128/JB.00580-17.
14. Jaganathan D, Ramasamy K, Sellamuthu G, Jayabalan S, Venkataraman G. CRISPR for crop improvement: an update review. Front Plant Sci. 2018;9:985. doi:10.3389/fpls.2018.00985.
15. Kourelis J, van der Hoorn RAL. Defended to the nines: 25 years of resistance gene cloning identifies nine mechanisms for R protein function. Plant Cell. 2018;30(2):285-99. doi:10.1105/tpc.17.00579.
16. Kumar K, Gambhir G, Dass A, Tripathi AK, Singh A, Jha AK, et al. Genetically modified crops: current status and future prospects. Planta. 2020;251:91. doi:10.1007/s00425-020-03372-8.
17. Nekrasov V, Staskawicz B, Weigel D, Jones JDG, Kamoun S. Targeted mutagenesis in the model plant Nicotiana benthamiana using Cas9 RNA-guided endonuclease. Nat Biotechnol. 2013;31(8):691-3. doi:10.1038/nbt.2655.
18. Oliva R, Ji C, Atienza-Grande G, Huguet-Tapia JC, Perez-Quintero A2, Li T, et al. Broad-spectrum resistance to bacterial blight in rice using genome editing. Nat Biotechnol. 2019;37(11):1344-50. doi:10.1038/s41587-019-0267-z.
19. Pavan S, Jacobsen E, Visser RGF, Bai Y. Loss of susceptibility as a novel breeding strategy for durable and broad-spectrum resistance. Mol Breed. 2010;25:112. doi:10.1007/s11032-009-9323-6.
20. Paul K, Saha S, Das S. Advances in CRISPR-Cas9 mediated genome editing for plant disease resistance. Physiol Mol Biol Plants. 2021;27:1-14. doi:10.1007/s12298-020-00923-0.
21. Peng A, Chen S, Lei T, Xu L, He Y, Wu L, et al. Engineering canker-resistant plants through CRISPR/Cas9-targeted editing of the susceptibility gene CsLOB1 promoter. Plant Biotechnol J. 2017;15(12):1509-19. doi:10.1111/pbi.12733.
22. Schaart JG, van de Wiel CCM, Lotz LAP, Smulders MJM. Opportunities for products of new plant breeding techniques. Trends Plant Sci. 2016;21(5):438-49. doi:10.1016/j.tplants.2015.11.006.
23. Tripathi JN, Ntui VO, Tripathi L. Application of genetic modification and genome editing for developing climate-smart banana. Food Energy Secur. 2020;9(2):e203. doi:10.1002/fes3.203.
24. Van Schie CCN, Takken FLW. Susceptibility genes 101: how to be a good host. Annu Rev Phytopathol. 2014;52:551-81. doi:10.1146/annurev-phyto-102313045854.
25. Wang F, Wang C, Liu P, Lei C, Hao W, Gao Y, et al. Enhanced rice blast resistance by CRISPR/Cas9targeted mutagenesis of the ERF transcription factor gene OsERF922. PLoS One. 2016;11(4):e0154027. doi:10.1371/journal.pone.0154027.
26. Yin K, Qiu JL. Genome editing for plant disease resistance: applications and perspectives. Philos Trans R Soc Lond B Biol Sci. 2019;374(1767):20180322. doi:10.1098/rstb.2018.0322.
27. Zaidi SS, Mahfouz MM, Mansoor S. CRISPR-Casmediated immunity in plants. Trends Plant Sci. 2017;22(11):1002-14. doi:10.1016/j.tplants.2017.08.012.
28. Zaidi SS, Mukhtar MS, Mansoor S. Genome editing: targeting susceptibility genes for plant disease resistance. Trends Biotechnol. 2018;36(9):898-906. doi:10.1016/j.tibtech.2018.04.005.